aminocaproic acid has been researched along with Acute Promyelocytic Leukemia in 3 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wassenaar, T | 1 |
| Black, J | 1 |
| Kahl, B | 1 |
| Schwartz, B | 1 |
| Longo, W | 1 |
| Mosher, D | 1 |
| Williams, E | 1 |
| Williams, EC | 1 |
| Ryo, R | 1 |
| Sugano, W | 1 |
| Yoshida, A | 1 |
| Adachi, M | 1 |
| Yasunaga, M | 1 |
| Yoneda, N | 1 |
| Saigo, K | 1 |
| Kondo, S | 1 |
| Yamaguchi, N | 1 |
| Nobusawa, A | 1 |
3 other studies available for aminocaproic acid and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients.
Topics: alpha-2-Antiplasmin; Aminocaproic Acid; Antifibrinolytic Agents; Drug Therapy, Combination; Female; | 2008 |
Plasma alpha 2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders.
Topics: Adolescent; alpha-2-Antiplasmin; Aminocaproic Acid; Blood Coagulation Disorders; Child; Disseminated | 1989 |
[Antiplasmin drugs and factor XIII concentrates in the treatment of a patient with acute promyelocytic leukemia (M3)].
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Disseminated Intravascular Coagulation; Drug Ther | 1989 |